TOMTEC-ARENA
TOMTEC Imaging Systems GmbH • Radiology • 08/14/2020
Device Purpose
TOMTEC-ARENA (TTA2.40) is a clinical software package designed to support diagnosis by enabling comprehensive quantification and reporting of cardiovascular, fetal, and abdominal structures using multi-dimensional medical image data. It employs advanced image processing, including 3D/4D modeling, speckle tracking, and machine learning algorithms, to provide detailed functional and morphological assessments for enhanced clinical decision-making.
Summary
TOMTEC-ARENA (TTA2.40) is an advanced clinical software package designed for the comprehensive review, quantification, and reporting of cardiovascular, fetal, and abdominal structures and functions from multi-dimensional digital medical data. Its primary purpose is to support physicians in diagnosing patients with suspected diseases by providing detailed analyses and measurements. The system comprises various modules, including 4D analysis tools for the left ventricle (LV), right ventricle (RV), and mitral valve (MV), as well as 2D cardiac performance analysis for adult and fetal hearts, and AutoStrain capabilities for LV, LA, and RV. It integrates with different imaging platforms, facilitating workflow through database management, data import/export, and archiving for reporting and statistical quantification. The software employs sophisticated image processing techniques, including 3D/4D modeling, speckle tracking for strain analysis, and machine learning algorithms for automated or semi-automated contour generation and landmark proposal, particularly in its 4D RV-Function, 4D MV-Assessment, and 4D LV-Analysis modules. Key updates in version TTA2.40 involve enhanced measurements (e.g., LA strain, additional MV parameters, renal vascular metrics), workflow improvements for user convenience, integration of new technologies like HeartModel auto-segmentation, and expansion of capabilities such as fetal cardiac analysis within 2D CPA and browser support for IMAGE-COM. Non-clinical testing confirmed that these modifications meet design and performance requirements, ensuring the software remains safe and effective for its intended clinical applications.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the integration of machine learning for contour generation in modules like 4D RV-Function and 4D MV-Assessment impact inter-observer variability compared to manual or previous semi-automated methods?; What specific validation studies were performed to confirm the accuracy of the newly added measurements, such as LA GLS in 4D LV-Analysis or the extended fetal 2D CPA parameters, against established gold standards or reference techniques?; Can the system quantify changes in myocardial mechanics or valvular geometry pre- and post-intervention, and how sensitive are these measurements to subtle pathological changes?; How does the TOMTEC-ARENA software handle image data from different ultrasound vendors, and what is the impact of varying image quality on the robustness and accuracy of its automated quantification algorithms?; What are the computational requirements for the advanced 4D analysis modules, and how does the browser-based TOMTEC ZERO solution for IMAGE-COM perform with large datasets in terms of speed and functionality compared to the FAT client?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM, SaaSBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly